Breakthroughs in Protecting Children From Ototoxicity

When people develop hearing or balance problems due to a medicine (as a side-effect), it’s called ototoxicity. An exciting consensus review on platinum-induced ototoxicity in children, co-authored by Dr. Brian Fligor, unveils promising strategies to protect young patients from hearing loss due to cancer treatment. There are two key chemotherapy agents that unfortunately cause significant hearing impairment in pediatric patients. This comprehensive review, summarizing insights from experts across various fields at the 42nd Congress of the International Society of Pediatric Oncology (SIOP) in Boston, highlights new research directions and the importance of international collaboration.

 

The study emphasizes the need for protective strategies that don’t compromise the efficacy of cancer treatment. Innovations involving antioxidant agents and careful consideration of drug administration timing offer hope for reducing hearing loss while maintaining effective cancer therapy. Get deeper into this study to explore how these groundbreaking efforts could safeguard the hearing of children undergoing life-saving cancer treatments.

 

Read the entire study HERE: https://pubmed.ncbi.nlm.nih.gov/22547603/

 

Prioritizing your children’s hearing health is as simple as contacting your local hearing experts at Tobias & Battite to schedule an appointment today!